Cardiopulmonary Disease
18
1
1
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.6%
1 terminated out of 18 trials
90.9%
+4.4% vs benchmark
0%
0 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (18)
The Effect of HIIT, MICT in Patients With Myocardial Infarction
Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
Clinical Validation Study for Noninvasive Cardiopulmonary Management Device
Fluid Status and Body Composition Analysis by Bioelectrical Impedance in Patients After Cardiac Surgery (FLUBIACS)
SGA for TEE: Safe Alternative to Deep Sedation for Patients With High-risk Cardiopulmonary Disease.
Respiration Validation for CPM Device
Unmasking Right Ventricular and Pulmonary Derangements With Exercise and Oxygen in Early Stage Cardiopulmonary Diseases
Exercise Strategies to Motivate and Relieve Stress
Comparing Inpatient COVID-19 Outcomes in 2 Different PT Dosing Groups
Acute Kidney Injury After Cardiac Surgery
Physiological Studies in Post-COVID-19 Syndrome, and the Association With DNA Methylation
Focused Cardiac Ultrasound in Surgery
IUGR, Respiratory Muscle Function, and Exercise Capacity in Childhood
Effects of Secondhand Smoke on Flight Attendant Health
Cardiopulmonary Outpatient Rehabilitation Using Mobile Technology
Indoor Air and Children Health Study
World Trade Center (WTC) RENAL
World Trade Center (WTC) CHEST